Abbott has released new global market research from its Beyond Intervention initiative, the company’s multi-year global research programme designed to examine the vascular patient experience from the perspectives of patients, physicians and healthcare leaders. The latest research focuses on challenges that arise for physicians and patients during the earliest stages of the patient journey, uncovering new opportunities for health systems and hospitals to leverage technology, break down existing barriers and improve patient care.

The findings from Beyond Intervention identify several key areas for improvement related to the diagnosis and treatment of cardiovascular disease. These include reducing inconsistencies in patient care delivery, improving access to technology to support accurate diagnosis, and addressing issues of health equity that result in inadequate care for underserved communities. The report also underscores the differences in how patients and healthcare providers perceive the effectiveness of the care being delivered.

"The latest data from the Beyond Intervention initiative reveals diverging views between patients and healthcare administrators on how each views the patient experience and the impact of inequities across the healthcare continuum," said Nick West MD, CMO and Divisional VP of medical affairs, Abbott’s vascular business.

Key insights from the research include:

• Improved patient experiences depend on appropriate intervention in the earliest stages of the healthcare journey.
• Health administrators and patients have differing views on the current patient experience.
• Lack of electronic medical record interoperability is causing more than patient frustration.
• Lack of standardised processes and technologies for diagnosis.
• Artificial intelligence (AI) and digital health solutions can improve patient care.
• Research reveals that people from underserved communities have greater challenges accessing care, understanding symptoms, and receiving diagnoses.